These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 34030480)
21. SIRT3 restricts hepatitis B virus transcription and replication through epigenetic regulation of covalently closed circular DNA involving suppressor of variegation 3-9 homolog 1 and SET domain containing 1A histone methyltransferases. Ren JH; Hu JL; Cheng ST; Yu HB; Wong VKW; Law BYK; Yang YF; Huang Y; Liu Y; Chen WX; Cai XF; Tang H; Hu Y; Zhang WL; Liu X; Long QX; Zhou L; Tao NN; Zhou HZ; Yang QX; Ren F; He L; Gong R; Huang AL; Chen J Hepatology; 2018 Oct; 68(4):1260-1276. PubMed ID: 29624717 [TBL] [Abstract][Full Text] [Related]
22. Early inhibition of hepatocyte innate responses by hepatitis B virus. Luangsay S; Gruffaz M; Isorce N; Testoni B; Michelet M; Faure-Dupuy S; Maadadi S; Ait-Goughoulte M; Parent R; Rivoire M; Javanbakht H; Lucifora J; Durantel D; Zoulim F J Hepatol; 2015 Dec; 63(6):1314-22. PubMed ID: 26216533 [TBL] [Abstract][Full Text] [Related]
23. HDV RNA replication is associated with HBV repression and interferon-stimulated genes induction in super-infected hepatocytes. Alfaiate D; Lucifora J; Abeywickrama-Samarakoon N; Michelet M; Testoni B; Cortay JC; Sureau C; Zoulim F; Dény P; Durantel D Antiviral Res; 2016 Dec; 136():19-31. PubMed ID: 27771387 [TBL] [Abstract][Full Text] [Related]
24. Poly(I:C) treatment leads to interferon-dependent clearance of hepatitis B virus in a hydrodynamic injection mouse model. Wu J; Huang S; Zhao X; Chen M; Lin Y; Xia Y; Sun C; Yang X; Wang J; Guo Y; Song J; Zhang E; Wang B; Zheng X; Schlaak JF; Lu M; Yang D J Virol; 2014 Sep; 88(18):10421-31. PubMed ID: 24920792 [TBL] [Abstract][Full Text] [Related]
25. Human induced pluripotent stem cell-derived hepatic cell lines as a new model for host interaction with hepatitis B virus. Kaneko S; Kakinuma S; Asahina Y; Kamiya A; Miyoshi M; Tsunoda T; Nitta S; Asano Y; Nagata H; Otani S; Kawai-Kitahata F; Murakawa M; Itsui Y; Nakagawa M; Azuma S; Nakauchi H; Nishitsuji H; Ujino S; Shimotohno K; Iwamoto M; Watashi K; Wakita T; Watanabe M Sci Rep; 2016 Jul; 6():29358. PubMed ID: 27386799 [TBL] [Abstract][Full Text] [Related]
26. Serum HBV DNA plus RNA shows superiority in reflecting the activity of intrahepatic cccDNA in treatment-naïve HBV-infected individuals. Huang H; Wang J; Li W; Chen R; Chen X; Zhang F; Xu D; Lu F J Clin Virol; 2018; 99-100():71-78. PubMed ID: 29353073 [TBL] [Abstract][Full Text] [Related]
27. Advances in Targeting the Innate and Adaptive Immune Systems to Cure Chronic Hepatitis B Virus Infection. Meng Z; Chen Y; Lu M Front Immunol; 2019; 10():3127. PubMed ID: 32117201 [TBL] [Abstract][Full Text] [Related]
28. Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro. Vincent IE; Lucifora J; Durantel D; Hantz O; Chemin I; Zoulim F; Trepo C Antivir Ther; 2009; 14(1):131-5. PubMed ID: 19320247 [TBL] [Abstract][Full Text] [Related]
29. Hepatitis B Gene Therapy Coming to Age. Soriano V AIDS Rev; 2018; 20(2):125-127. PubMed ID: 29938706 [TBL] [Abstract][Full Text] [Related]
30. Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients. Testoni B; Lebossé F; Scholtes C; Berby F; Miaglia C; Subic M; Loglio A; Facchetti F; Lampertico P; Levrero M; Zoulim F J Hepatol; 2019 Apr; 70(4):615-625. PubMed ID: 30529504 [TBL] [Abstract][Full Text] [Related]
31. Down-regulation of cell membrane localized NTCP expression in proliferating hepatocytes prevents hepatitis B virus infection. Yan Y; Allweiss L; Yang D; Kang J; Wang J; Qian X; Zhang T; Liu H; Wang L; Liu S; Sui J; Chen X; Dandri M; Zhao J; Lu F Emerg Microbes Infect; 2019; 8(1):879-894. PubMed ID: 31179847 [TBL] [Abstract][Full Text] [Related]
32. Interferon-β response is impaired by hepatitis B virus infection in Tupaia belangeri. Kayesh MEH; Ezzikouri S; Chi H; Sanada T; Yamamoto N; Kitab B; Haraguchi T; Matsuyama R; Nkogue CN; Hatai H; Miyoshi N; Murakami S; Tanaka Y; Takano JI; Shiogama Y; Yasutomi Y; Kohara M; Tsukiyama-Kohara K Virus Res; 2017 Jun; 237():47-57. PubMed ID: 28551415 [TBL] [Abstract][Full Text] [Related]
33. Nuclear Sensor Interferon-Inducible Protein 16 Inhibits the Function of Hepatitis B Virus Covalently Closed Circular DNA by Integrating Innate Immune Activation and Epigenetic Suppression. Yang Y; Zhao X; Wang Z; Shu W; Li L; Li Y; Guo Z; Gao B; Xiong S Hepatology; 2020 Apr; 71(4):1154-1169. PubMed ID: 31402464 [TBL] [Abstract][Full Text] [Related]
34. Hepatitis B surface antigen: relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B. Manesis EK; Papatheodoridis GV; Tiniakos DG; Hadziyannis ES; Agelopoulou OP; Syminelaki T; Papaioannou C; Nastos T; Karayiannis P J Hepatol; 2011 Jul; 55(1):61-8. PubMed ID: 21145875 [TBL] [Abstract][Full Text] [Related]
35. Hepatitis B e Antigen Inhibits NF-κB Activity by Interrupting K63-Linked Ubiquitination of NEMO. Wang Y; Cui L; Yang G; Zhan J; Guo L; Chen Y; Fan C; Liu D; Guo D J Virol; 2019 Jan; 93(2):. PubMed ID: 30404796 [TBL] [Abstract][Full Text] [Related]
36. Activating the innate immune response to counter chronic hepatitis B virus infection. Lamb C; Arbuthnot P Expert Opin Biol Ther; 2016 Dec; 16(12):1517-1527. PubMed ID: 27603796 [TBL] [Abstract][Full Text] [Related]
37. Serum Hepatitis B Virus DNA, RNA, and HBsAg: Which Correlated Better with Intrahepatic Covalently Closed Circular DNA before and after Nucleos(t)ide Analogue Treatment? Gao Y; Li Y; Meng Q; Zhang Z; Zhao P; Shang Q; Li Y; Su M; Li T; Liu X; Zhuang H J Clin Microbiol; 2017 Oct; 55(10):2972-2982. PubMed ID: 28747369 [TBL] [Abstract][Full Text] [Related]
38. Presence of entry receptors and viral markers suggest a low level of placental replication of hepatitis B virus in a proportion of pregnant women infected with chronic hepatitis B. Garg G; Meenu MN; Patel K; Singh R; Gupta P; Purwar S; Mukhopadhyay S; Mishra N; Gupta S; Rawat SK; Goel H; Kumar R; Tanwar P; Singh J; Nema S; Biswas D; Trehanpati N; Singh AK; Vyas AK Sci Rep; 2022 Oct; 12(1):17795. PubMed ID: 36272995 [TBL] [Abstract][Full Text] [Related]
39. Mechanisms downstream of reverse transcription reduce serum levels of HBV DNA but not of HBsAg in chronic hepatitis B virus infection. Larsson SB; Malmström S; Hannoun C; Norkrans G; Lindh M Virol J; 2015 Dec; 12():213. PubMed ID: 26645241 [TBL] [Abstract][Full Text] [Related]
40. The innate immune response to hepatitis B virus infection: implications for pathogenesis and therapy. Chang J; Block TM; Guo JT Antiviral Res; 2012 Dec; 96(3):405-13. PubMed ID: 23072881 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]